Showing results (211-220 of 227) with videos related to
Sort By:
Pageof 23
Scandinavian Journal of Urology and Nephrology|January 1, 1984
Unexpected urethral strictures after short-term catheterization in open-heart surgeryM Ruutu, O Alfthan, L Heikkinen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Association of E-cadherin germ-line alterations with prostate cancerT Ikonen, M Matikainen, N Mononen, et al.Nature Communications|March 23, 2018
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progressionLeena Latonen, Ebrahim Afyounian, Antti Jylhä, et al.International Urology and Nephrology|January 1, 1992
Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancerI Elomaa, T Kylmälä, T Tammela, et al.Annales Chirurgiae Et Gynaecologiae|January 1, 1985
Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate)R Haapiainen, S Rannikko, M Ruutu, et al.British Journal of Cancer|January 11, 2007
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trialL Määttänen, M Hakama, T L J Tammela, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancerS Pyrhönen, E Salminen, M Ruutu, et al.Urology|April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trialsR Hall, P O Hedlund, R Ackermann, et al.Calcified Tissue International|September 18, 2007
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone diseaseJ E Brown, E V McCloskey, J A Dewar, et al.Neurourology and Urodynamics|March 25, 1999
Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study GroupT L Tammela, W Schäfer, D M Barrett, et al.Pageof 23